Steward Partners Investment Advisory, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$7,000
+75.0%
1100.0%0.00%
Q2 2022$4,000
-33.3%
110
-37.1%
0.00%
Q1 2022$6,000
+20.0%
1750.0%0.00%
Q4 2021$5,000
+25.0%
1750.0%0.00%
Q3 2021$4,000
-50.0%
175
-22.2%
0.00%
Q2 2021$8,000
-100.0%
225
-82.0%
0.00%
Q1 2021$50,938,000
+121181.0%
1,250
+27.6%
0.00%
-100.0%
Q4 2020$42,000
-38.2%
980
-20.7%
0.00%
-50.0%
Q3 2020$68,000
+11.5%
1,236
+27.0%
0.00%0.0%
Q2 2020$61,000
+35.6%
973
+10.2%
0.00%0.0%
Q1 2020$45,000
+4.7%
883
+62.0%
0.00%
+100.0%
Q4 2019$43,000
+65.4%
5450.0%0.00%0.0%
Q3 2019$26,000
-3.7%
545
+4.8%
0.00%0.0%
Q2 2019$27,000
+107.7%
520
+46.5%
0.00%0.0%
Q3 2018$13,000
-18.8%
3550.0%0.00%0.0%
Q2 2018$16,0000.0%355
+4.4%
0.00%0.0%
Q1 2018$16,000
-42.9%
340
-52.6%
0.00%
-50.0%
Q4 2017$28,000
+27.3%
7170.0%0.00%0.0%
Q3 2017$22,000
+15.8%
7170.0%0.00%0.0%
Q2 2017$19,000
+35.7%
717
+85.8%
0.00%0.0%
Q1 2017$14,0003860.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders